Drug Profile
Pneumococcal vaccine conjugate - Merck & Co
Latest Information Update: 12 Feb 2008
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Conjugate vaccines; Pneumococcal vaccines; Polysaccharides
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pneumococcal infections
Most Recent Events
- 12 Feb 2008 Discontinued - Clinical-Phase-Unknown for Pneumococcal infections in Israel (IM)
- 12 Feb 2008 Discontinued - Phase-II for Pneumococcal infections in Finland (IM)
- 12 Feb 2008 Discontinued - Phase-III for Pneumococcal infections in USA (IM)